Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.

av Poewe, W, Schelosky, L, Kleedorfer, B
Publicerad 1991

Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease.

av Kleedorfer, B, Lees, A J, Stern, G M
Publicerad 1991

Buspirone in the treatment of levodopa induced dyskinesias.

av Kleedorfer, B, Lees, A J, Stern, G M
Publicerad 1991

The dopaminergic response in multiple system atrophy.

av Hughes, A J, Colosimo, C, Kleedorfer, B, Daniel, S E, Lees, A J
Publicerad 1992

Ropinirole (SK and F 101468) in the treatment of Parkinson's disease.

av Kleedorfer, B, Stern, G M, Lees, A J, Bottomley, J M, Sree-Haran, N
Publicerad 1991

Intranasal apomorphine: a new treatment in Parkinson's disease.

av Kapoor, R, Turjanski, N, Frankel, J, Kleedorfer, B, Lees, A, Stern, G, Bovingdon, M, Webster, R
Publicerad 1990

Sublingual apomorphine and Parkinson's disease.

av Lees, A J, Montastruc, J L, Turjanski, N, Rascol, O, Kleedorfer, B, Peyro Saint-Paul, H, Stern, G M, Rascol, A
Publicerad 1989

Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

av Hyman, N, Barnes, M, Bhakta, B, Cozens, A, Bakheit, M, Kreczy-Kleedorfer, B, Poewe, W, Wissel, J, Bain, P, Glickman, S, Sayer, A, Richardson, A, Dott, C
Publicerad 2000